Member Info for wozzer70

There was certainly excitement ahead of the Lucyd IPO, although the portfolio looked very different at the time. In hindsight, the IPO itself didn't drive a lasting rerating because investors still wanted to see commercial execution afterwards. What feels different today is that several portfolio companies have progressed, and Guident already has live deployments and operational data that the market can evaluate.

Today’s mix of updates highlights why many investors take a long-term view of TEK. Individual portfolio companies will inevitably progress at different speeds, and short-term developments in one asset do not necessarily alter the trajectory of another.

With Guident continuing to expand its Florida deployments and progress its regulatory engagement, the operational foundation appears to be moving forward. Day-to-day sentiment will fluctuate, but the most useful reference points remain the official filings and the underlying operational data.

With operational activity continuing to build, attention now naturally turns to Guident's next filings 🧐

Interesting to see the steady increase in usage and planned expansion at Mizner Park. The combination of live deployment, regulatory engagement and remote monitoring infrastructure is probably the most relevant part here, especially as the route scales into higher-density areas like Royal Palm Plaza.

A quick reminder for anyone following the story:

Investment decisions should be based on official company filings, not message board sentiment.

Every update I post is sourced from publicly available SEC EDGAR filings, company announcements and LSE regulatory releases.

My focus remains simple:

* Following the Guident listing process

* Tracking portfolio company progress

* Monitoring audited financial data

* Assessing how those developments impact TEK's valuation over time.

Everyone is free to draw their own conclusions.

I filter out the personal abuse/noise and focus entirely on the math. The filings are public for anyone who prefers research over rhetoric.

Baseline support continues to hold while investors wait for the next major catalyst.

Guident has spent the waiting period updating financials, restructuring its banking team and refining its proposed Nasdaq listing.

The process has taken longer than many expected, but the registration remains active and management continues to reference a 2026 listing objective.

Real technology. Real autonomous vehicle monitoring deployments. Real revenue growth.

Now the market waits for the next chapter

https://docs.google.com/document/d/12AXekfMiPgzH3NpokvrMCCTe8l0QNIoxjFLNspCK61w/edit?usp=drivesdk

There are a few factors that support the possibility that the IPO process could move faster than many investors have become accustomed to:

• U.S. regulators have been discussing ways to reduce unnecessary friction in capital markets.

• There has been industry-wide discussion around streamlining parts of the IPO review process.

• Efficient markets generally benefit when growth companies can access public capital more effectively.

• Most importantly, Guident is not starting from scratch. The company has already filed, responded to comments, submitted amendments and remains within the review process.

What we do not know is where Guident currently sits within that process.

That is the missing piece.

The next few weeks could be an important period to watch for Guident.

Historically, June is one of the stronger windows for new listings, while July and August often see lower market participation as the summer holiday season begins.

That doesn't mean the SEC works to a market calendar, but it does mean that if the review process concludes in the near term, Guident would potentially have the opportunity to enter the market during a period that typically offers better liquidity and investor engagement.

For me, that's why June feels significant.

Not because anything is guaranteed, but because the combination of SEC progress and market timing could become increasingly relevant over the next few weeks.

When that SEC "Effectiveness" notice lands for Guident, the transformation will be instant:

The Valuation Shift: It turns a speculative private asset into an undeniable, externally priced public company.

The Liquidity Event: It opens the door for immediate corporate actions, structural re-ratings, and capital flexibility that the bears on the board claim are impossible.

The Legal Checkmate: A formal regulatory green light completely bypasses all the forum noise, theories, and unhinged insults.

Onwards and upwards 🎯

When a board becomes heavily focused on short-term sentiment, it’s easy to lose sight of the underlying structure of the investment case.

For me, the key inflection point in TEK remains the potential Guident listing.

If that completes successfully, it changes the framework in three important ways:

1, Reduced “private valuation discount”A public listing replaces internal portfolio valuation uncertainty with market pricing, which typically narrows the holding company discount.

2, Structural liquidity improvement, A listed asset base creates clearer pathways for capital recycling and strengthens balance sheet flexibility across the group.

3, Validation of the portfolio model with multiple portfolio companies listed, TEK moves from a single-case story to a repeatable incubation track record, which is what ultimately attracts more institutional attention over time.

Until then, sentiment will likely remain volatile and divided.

For me, the focus is on the structural endpoint rather than the day-to-day noise along the way.

While the board debates short-term sentiment, looking at the actual structural framework of the business model reveals a company quietly maturing.

1, Lean Operations: Total annual expenses were cut by 7% to $1.88M, continuing a multi-year trend of strict cost discipline. Management is running this efficiently.

2, The Liquidity Transition: Most core holdings are now publicly listed and transparently priced. We are no longer waiting on "soft" internal valuations; the market prices the assets daily.

3, The AI Optionality: The brand-new launch of Vesari Inc introduces a capital-light entry into geothermal-powered AI data center infrastructure. It addresses the massive grid bottleneck facing AI compute, giving TEK a ground-floor asset in a hyper-growth sector with no immediate cash strain on the parent company.

At a 15M market cap, the sum of these moving listed parts - combined with the upcoming Guident catalyst - presents an asymmetric risk/reward that goes far beyond standard accounting noise.

The market is still pricing TEK like a concept.

Guident has the potential to change that into a validated asset.

That’s the difference between speculation and recognition.

The SEC process is frustrating, but it also means this remains a live process, not a dead one.

Guident listing successfully wouldn’t just move Guident. It would force the market to reassess TEK itself.

Sometimes you need to step back from the daily share price noise and look at where TEK actually sits in its lifecycle.

Most early-stage portfolio companies look messy before they look successful. That’s the nature of incubation investing: years of funding, development, commercial traction building, then eventually a validation event.

Right now the market is still pricing TEK mainly through: dilution fatigue, delays, and weak trust.

But operationally the portfolio is not standing still: SALT revenues are growing, GNIP revenues are accelerating, LUCY continues expanding distribution, and Guident is still progressing through the SEC process toward a proposed US listing.

That’s the key point for me.

The market today is acting as though nothing has been built. The filings suggest the opposite: the structure is now approaching the stage where external validation matters more than internal promises.

And if Guident successfully lists, I genuinely think the market dynamic changes in phases: first relief, then credibility returning, then a reassessment of the wider TEK portfolio.

That’s why I still believe Guident is the defining piece of the puzzle.

Everything before that is mostly noise.

Fair points on concentration risk and the need for real delivered growth rather than just guidance.

But I also think the debate has shifted meaningfully over the last 18 months.

Previously the question was whether MicroSalt could achieve meaningful commercial adoption at all.

Now the market discussion is more about scaling pace, execution and profitability.

That doesn’t remove risk, but it does suggest the company has moved beyond purely theoretical commercialisation.

Worth noting the SALT results quietly strengthen the broader TEK framework argument.

This is no longer just a “concept story”. Revenue nearly tripled, losses reduced, recurring multinational orders expanded and 2027 projections were reaffirmed.

The market may still discount execution risk heavily, but operational traction across the portfolio is becoming harder to ignore.

Guident remains the major sentiment catalyst, but SALT now looks increasingly like a genuine commercial scaling asset rather than a speculative side project

The key thing in the SALT results for me wasn’t the short-term FY26 timing adjustment.

It was the continued evidence that MicroSalt is moving from “technology story” into repeat commercial adoption with multinational food groups.

Recurring orders, expanding rollout pathways, improving losses and reaffirmed 2027 projections all suggest scaling momentum is still building.

The market will decide later whether execution fully lands, but operationally this reads far stronger than a business in decline

The podcast was never likely to contain a dramatic Guident reveal because once an IPO process is active, communication becomes tightly restricted around anything that could be seen as promotional.

What it did do was quietly reinforce several important points:

• Guident is still progressing through the SEC review pathway

• management are still openly referencing a 2026 listing outcome

• portfolio companies are showing operational growth

• Vesari is expected to seek external funding, limiting immediate TEK balance sheet pressure

• TEK still intends to expand the portfolio selectively where opportunities fit the model

For me, the value of the podcast was not hype. It was confirmation that the broader framework still appears intact while the market waits for the one thing that matters most now:

external validation through successful execution.

The podcast was about as close as you get to a guident update without crossing the line. The IPO couldn’t be talked up aggressively due to the "sec" legalities, but the 2026 listing reference and Guident’s growth numbers make the direction of travel pretty clear.

The podcast is a timely reminder that TEK’s story is now about execution and validation, not just NAV discounts. Vesari adds optionality, but Guident is still the big market trigger.

It should give investors a bit more confidence that the portfolio is moving from story to validation, with Guident still the key near-term catalyst.

(Podcast)

The Guident IPO and AI data centres with Tekcapital...

https://ukinvestormagazine.co.uk/the-guident-ipo-and-ai-data-centres-with-tekcapital/

Tek’s latest RNS and recent price action suggest the market has largely priced in the NAV noise and is now watching the “prove it” phase with the Guident IPO.

We’re sitting around a key multi‑year support area near 6p with the RSI in deeply oversold territory, which is often where bigger moves start when real volume returns.

For me, the real catalyst is clear: once Guident’s IPO delivers an externally validated valuation benchmark for a major TEK holding, the scope for a Phase 1 rerate grows as the sum‑of‑parts becomes harder to ignore.

In the near term I’m watching for a move back towards the 50‑day around 7p and then a push into the 8p region if the Guident newsflow lands well.